I have previously been critical of the US rollout, which has been slow - but the numbers on a raw basis aren't that bad compared to NZL and ROW lately. You see that Australian numbers still taking off in that time period, and I think its important to remember the uptake of software and tech is often non-linear.
Since H1 FY20
NZL +169k
USA +139k
UK +358k
ROW +143k
AUS +630k
If you look at the addressable markets, they have 2m of the 3.7m addressable market in AUNZL. They are now starting to garner a really decent portion of the UK market with almost 900k of 5.5m, which is reaching a solid tipping point now and momentum should hopefully keep going. I think realistically, the size of the US addressable market is just too big to not try for, even if you only ever garner 10% of it (currently they have 1%), that is the size of the entire current subscriber base.
You also have an increase of 31% in platform revenues, these revenues from the last report are annualized $144m, and very high margin. These are the types of revenues that we really like to see increase for markets like the US/UK as you have Apps taking care of localized reporting requirements while using the core functionality of Xero.
So it will be an interesting time, but I think the doom about the US market is probably a little overstated considering the upside if they get it even a little right.
- Forums
- ASX - By Stock
- XRO
- Ann: H1 FY23 Investor Presentation
Ann: H1 FY23 Investor Presentation, page-69
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XRO (ASX) to my watchlist
|
|||||
Last
$135.87 |
Change
2.340(1.75%) |
Mkt cap ! $20.73B |
Open | High | Low | Value | Volume |
$133.87 | $135.87 | $133.73 | $39.94M | 295.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 308 | $135.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$135.89 | 360 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 900 | 135.310 |
1 | 167 | 134.920 |
1 | 823 | 134.900 |
1 | 2824 | 134.890 |
1 | 616 | 134.790 |
Price($) | Vol. | No. |
---|---|---|
135.900 | 1210 | 4 |
135.990 | 200 | 1 |
136.000 | 1138 | 12 |
136.050 | 823 | 1 |
136.400 | 5 | 2 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
XRO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online